Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Porter

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Oncology (Williston Park, N.Y.)|November 11, 2003
Combining artificial neural networks and transrectal ultrasound in the diagnosis of prostate cancerChristopher R Porter, E David Crawford
The Urologic Clinics of North America|November 3, 2011
The history and anatomy of urologic lymphadenectomyDaniel J Lewinshtein, Christopher R Porter
The Journal of Urology|February 14, 2006
Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black american men but not in white men: results from a consecutive series of 914 menKalyan C Latchamsetty, Jason Kim, Christopher R Porter
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Evaluation and Preservation of Fertility in Patients with Testicular CancerSiamak Daneshmand, Hooman Djaladat, Christopher R Porter, et al.
BJU International|January 8, 2010
Radical retropubic cystectomyMichael A Traver, E Darracott Vaughan, Christopher R Porter
Expert Review of Molecular Diagnostics|July 16, 2010
Genomic predictors of prostate cancer therapy outcomesDaniel J Lewinshtein, Christopher R Porter, Peter S Nelson
Seminars in Oncology|March 3, 2011
Quantitative ultrasound in cancer imagingErnest J Feleppa, Jonathan Mamou, Christopher R Porter, et al.
BJU International|September 3, 2011
Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminomaDan Lewinshtein, Roman Gulati, Peter S Nelson, et al.
Clinical Prostate Cancer|July 5, 2005
Absence of lower urinary tract symptoms is an independent predictor for cancer at prostate biopsy, but prostate-specific antigen is not: results from a prospective series of 569 patientsChristopher R Porter, Kalyan C Latchamsetty, Christopher L Coogan, et al.
Advances in Urology|September 24, 2011
The long-term outcomes after radical prostatectomy of patients with pathologic Gleason 8-10 diseaseDan Lewinshtein, Brandon Teng, Ashley Valencia, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Oncology (Williston Park, N.Y.)|November 11, 2003
Combining artificial neural networks and transrectal ultrasound in the diagnosis of prostate cancerChristopher R Porter, E David Crawford
The Urologic Clinics of North America|November 3, 2011
The history and anatomy of urologic lymphadenectomyDaniel J Lewinshtein, Christopher R Porter
The Journal of Urology|February 14, 2006
Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black american men but not in white men: results from a consecutive series of 914 menKalyan C Latchamsetty, Jason Kim, Christopher R Porter
Journal of Adolescent and Young Adult Oncology|January 27, 2016
Evaluation and Preservation of Fertility in Patients with Testicular CancerSiamak Daneshmand, Hooman Djaladat, Christopher R Porter, et al.
BJU International|January 8, 2010
Radical retropubic cystectomyMichael A Traver, E Darracott Vaughan, Christopher R Porter
Expert Review of Molecular Diagnostics|July 16, 2010
Genomic predictors of prostate cancer therapy outcomesDaniel J Lewinshtein, Christopher R Porter, Peter S Nelson
Seminars in Oncology|March 3, 2011
Quantitative ultrasound in cancer imagingErnest J Feleppa, Jonathan Mamou, Christopher R Porter, et al.
BJU International|September 3, 2011
Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminomaDan Lewinshtein, Roman Gulati, Peter S Nelson, et al.
Clinical Prostate Cancer|July 5, 2005
Absence of lower urinary tract symptoms is an independent predictor for cancer at prostate biopsy, but prostate-specific antigen is not: results from a prospective series of 569 patientsChristopher R Porter, Kalyan C Latchamsetty, Christopher L Coogan, et al.
Advances in Urology|September 24, 2011
The long-term outcomes after radical prostatectomy of patients with pathologic Gleason 8-10 diseaseDan Lewinshtein, Brandon Teng, Ashley Valencia, et al.
Pageof 6